SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden

Conclusion: For 18F-DCFPyL PET/CT, SUVpeak correlates strongly with TBR. Therefore, it is a valuable simplified, semiquantitative measurement in patients with low-volume PCa (<200 cm3). SUVpeak can therefore be applied in 18F-DCFPyL PET assessment as an imaging biomarker to characterize tumors and to monitor treatment outcomes.

Source: Journal of Nuclear Medicine - September 2, 2021 Category: Nuclear Medicine Authors: Bodar, Y. J. L., Koene, B. P. F., Jansen, B. H. E., Cysouw, M. C. F., Meijer, D., Hendrikse, N. H., Vis, A. N., Boellaard, R., Oprea-Lager, D. E. Tags: Clinical Source Type: research